$3.18
1.85% yesterday
Nasdaq, Sep 12, 10:00 pm CET
ISIN
US81728J1097
Symbol
SRTS

Sensus Healthcare, Inc. Stock price

$3.18
-0.09 2.75% 1M
-1.40 30.57% 6M
-3.74 54.05% YTD
-2.67 45.64% 1Y
-10.57 76.87% 3Y
+0.49 18.22% 5Y
-2.67 45.64% 10Y
-2.67 45.64% 20Y
Nasdaq, Closing price Fri, Sep 12 2025
-0.06 1.85%

Key metrics

Basic
Market capitalization
$52.3m
Enterprise Value
$30.1m
Net debt
positive
Cash
$22.2m
Shares outstanding
16.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.4 | 1.5
EV/Sales
0.8 | 0.9
EV/FCF
8.6
P/B
1.0
Financial Health
Equity Ratio
89.8%
Return on Equity
11.9%
ROCE
-2.6%
ROIC
-7.7%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$37.6m | $35.1m
EBITDA
$-830.0k | $5.1m
EBIT
$-1.4m | $-4.0m
Net Income
$-850.0k | $-2.1m
Free Cash Flow
$3.5m
Growth (TTM | estimate)
Revenue
3.3% | -15.9%
EBITDA
-109.4% | -40.3%
EBIT
-116.0% | -149.9%
Net Income
-112.8% | -131.3%
Free Cash Flow
420.2%
Margin (TTM | estimate)
Gross
52.2%
EBITDA
-2.2% | 14.5%
EBIT
-3.6%
Net
-2.3% | -5.9%
Free Cash Flow
9.3%
More
EPS
$-0.1
FCF per Share
$0.2
Short interest
5.5%
Employees
54
Rev per Employee
$770.0k
Show more

Is Sensus Healthcare, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

Sensus Healthcare, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Sensus Healthcare, Inc. forecast:

10x Buy
91%
1x Hold
9%

Analyst Opinions

11 Analysts have issued a Sensus Healthcare, Inc. forecast:

Buy
91%
Hold
9%

Financial data from Sensus Healthcare, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
38 38
3% 3%
100%
- Direct Costs 18 18
24% 24%
48%
20 20
11% 11%
52%
- Selling and Administrative Expenses 14 14
48% 48%
39%
- Research and Development Expense 6.50 6.50
83% 83%
17%
-0.83 -0.83
109% 109%
-2%
- Depreciation and Amortization 0.54 0.54
74% 74%
1%
EBIT (Operating Income) EBIT -1.37 -1.37
116% 116%
-4%
Net Profit -0.85 -0.85
113% 113%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about Sensus Healthcare, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sensus Healthcare, Inc. Stock News

Neutral
GlobeNewsWire
4 days ago
Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Sensus (SRTS) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Sensus and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
Neutral
GlobeNewsWire
13 days ago
Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Sensus (SRTS) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Sensus and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
Neutral
GlobeNewsWire
15 days ago
Investors can contact the law firm at no cost to learn more about recovering their losses
More Sensus Healthcare, Inc. News

Company Profile

Sensus Healthcare, Inc. operates as a medical device company, which provides treatments for both oncological and non-oncological skin conditions. The firm's portfolio of treatment devices includes the SRT-100, SRT-100+ and SRT-100 Vision. Its main product, superficial radiation therapy (SRT), a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers and other skin conditions such as keloids. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

Head office United States
CEO Joseph Sardano
Employees 54
Founded 2010
Website sensushealthcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today